BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Likhitsup A, Parikh ND. Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians. Pharmacoeconomics 2020;38:5-24. [PMID: 31573053 DOI: 10.1007/s40273-019-00839-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang A, Chang SH, Kim EJ, Bessich JL, Sabari JK, Cooper B, Geraci TC, Cerfolio RJ. Dynamic Management of Lung Cancer Care During Surging COVID-19. Front Surg 2021;8:663364. [PMID: 33898509 DOI: 10.3389/fsurg.2021.663364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Straś W, Gotlib J, Małkowski P, Wasiak D, Śliwczyński A, Panczyk M, Tronina O, Brzozowska M. Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience. Med Sci Monit 2021;27:e931856. [PMID: 34462415 DOI: 10.12659/MSM.931856] [Reference Citation Analysis]
3 Carter HE, Jeffrey GP, Ramm GA, Gordon LG. Cost-Effectiveness of a Serum Biomarker Test for Risk-Stratified Liver Ultrasound Screening for Hepatocellular Carcinoma. Value Health 2021;24:1454-62. [PMID: 34593168 DOI: 10.1016/j.jval.2021.04.1286] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Piskin FC, Balli HT, Erdoğan KE, Sozutok S, Aikimbaev K. Whole tumor volumetric ADC analysis: relationships with histopathological differentiation of hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:5180-9. [PMID: 34415410 DOI: 10.1007/s00261-021-03240-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Häfner SJ. High hopes and high honours for cancer immunotherapy. Biomed J 2019;42:293-8. [PMID: 31783989 DOI: 10.1016/j.bj.2019.10.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Liu H, Li D, Zhou L, Kan S, He G, Zhou K, Wang L, Chen M, Shu W. LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability. J Cell Mol Med 2020;24:12008-19. [PMID: 32896989 DOI: 10.1111/jcmm.15829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]